{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:17:10Z","timestamp":1793852230935,"version":"4.6.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003356","name":"Gazi University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003356","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Nutr Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose of Review<\/jats:title>\n                <jats:p>The gut microbiota plays a crucial role in the pathogenesis of neuroinflammation and Alzheimer\u2019s and Parkinson\u2019s diseases. One of the main modulators of the gut microbiota is the diet, which directly influences host homeostasis and biological processes. Some dietary patterns can affect neurodegenerative diseases\u2019 progression through gut microbiota composition, gut permeability, and the synthesis and secretion of microbial-derived neurotrophic factors and neurotransmitters. This comprehensive review critically assesses existing studies investigating the impact of dietary interventions on the modulation of the microbiota in relation to neurodegenerative diseases and neuroinflammation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent Findings<\/jats:title>\n                <jats:p>There are limited studies on the effects of specific diets, such as the ketogenic diet, Mediterranean diet, vegetarian diet, and Western diet, on the progression of neuroinflammation and Alzheimer\u2019s and Parkinson\u2019s diseases through the gut-brain axis. The ketogenic diet displays promising potential in ameliorating the clinical trajectory of mild cognitive impairment and Alzheimer\u2019s disease. However, conflicting outcomes were observed among various studies, highlighting the need to consider diverse types of ketogenic diets and their respective effects on clinical outcomes and gut microbiota composition. Vegetarian and Mediterranean diets, known for their anti-inflammatory properties, can be effective against Parkinson\u2019s disease, which is related to inflammation in the gut environment. On the other hand, the westernization of dietary patterns was associated with reduced gut microbial diversity and metabolites, which ultimately contributed to the development of neuroinflammation and cognitive impairment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>Various studies examining the impact of dietary interventions on the gut-brain axis with regard to neuroinflammation and Alzheimer\u2019s and Parkinson\u2019s diseases are thoroughly reviewed in this article. A strong mechanistic explanation is required to fully understand the complex interactions between various dietary patterns, gut microbiota, and microbial metabolites and the effects these interactions have on cognitive function and the progression of these diseases.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s13668-024-00539-7","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T05:01:27Z","timestamp":1713848487000},"page":"82-96","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Modulation of Gut Microbiota Through Dietary Intervention in Neuroinflammation and Alzheimer\u2019s and Parkinson\u2019s Diseases"],"prefix":"10.1007","volume":"13","author":[{"given":"\u015eerife","family":"Ayten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saniye","family":"Bilici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,23]]},"reference":[{"issue":"3","key":"539_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","volume":"19","author":"VL Feigin","year":"2020","unstructured":"Feigin VL, et al. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol. 2020;19(3):255\u201365.","journal-title":"Lancet Neurol"},{"issue":"1","key":"539_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","volume":"18","author":"E Nichols","year":"2019","unstructured":"Nichols E, et al. Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(1):88\u2013106.","journal-title":"Lancet Neurol"},{"key":"539_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102950","volume":"59","author":"R Nagpal","year":"2020","unstructured":"Nagpal R, et al. Gut mycobiome and its interaction with diet, gut bacteria and Alzheimer\u2019s disease markers in subjects with mild cognitive impairment: a pilot study. EBioMedicine. 2020;59: 102950.","journal-title":"EBioMedicine"},{"issue":"1","key":"539_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","volume":"75","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Bloem BR. The Parkinson pandemic\u2014a call to action. JAMA Neurol. 2018;75(1):9\u201310.","journal-title":"JAMA Neurol"},{"issue":"6","key":"539_CR5","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell. 2016;167(6):1469-1480. e12.","journal-title":"Cell"},{"issue":"40","key":"539_CR6","doi-asserted-by":"publisher","first-page":"10713","DOI":"10.1073\/pnas.1711235114","volume":"114","author":"E Cekanaviciute","year":"2017","unstructured":"Cekanaviciute E, et al. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc Natl Acad Sci. 2017;114(40):10713\u20138.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"539_CR7","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/j.cell.2019.05.004","volume":"177","author":"G Sharon","year":"2019","unstructured":"Sharon G, et al. Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice. Cell. 2019;177(6):1600-1618. e17.","journal-title":"Cell"},{"issue":"340","key":"539_CR8","doi-asserted-by":"publisher","first-page":"340ra72","DOI":"10.1126\/scitranslmed.aaf1059","volume":"8","author":"DKV Kumar","year":"2016","unstructured":"Kumar DKV, et al. Amyloid-\u03b2 peptide protects against microbial infection in mouse and worm models of Alzheimer\u2019s disease. Science Transl Med. 2016;8(340):340ra72-340ra72.","journal-title":"Science Transl Med"},{"issue":"4","key":"539_CR9","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3233\/JAD-180176","volume":"63","author":"Z-Q Zhuang","year":"2018","unstructured":"Zhuang Z-Q, et al. Gut microbiota is altered in patients with Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. 2018;63(4):1337\u201346.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"1","key":"539_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"N Saji","year":"2019","unstructured":"Saji N, et al. The relationship between the gut microbiome and mild cognitive impairment in patients without dementia: a cross-sectional study conducted in Japan. Sci Rep. 2019;9(1):1\u201310.","journal-title":"Sci Rep"},{"issue":"2","key":"539_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s13238-016-0338-6","volume":"8","author":"R Alkasir","year":"2017","unstructured":"Alkasir R, et al. Human gut microbiota: the links with dementia development. Protein Cell. 2017;8(2):90\u2013102.","journal-title":"Protein Cell"},{"key":"539_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ebiom.2019.08.032","volume":"47","author":"R Nagpal","year":"2019","unstructured":"\u2022\u2022 Nagpal R, et al. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer\u2019s disease markers in subjects with mild cognitive impairment. EBioMedicine. 2019;47:529\u201342. According to the research, certain gut microbial signatures may indicate MCI, and MMKD may modulate gut metabolites and microbiome in correlation with enhanced AD biomarkers in CSF.","journal-title":"EBioMedicine"},{"issue":"1","key":"539_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s13311-017-0598-8","volume":"15","author":"LM Cox","year":"2018","unstructured":"Cox LM, Weiner HL. Microbiota signaling pathways that influence neurologic disease. Neurotherapeutics. 2018;15(1):135\u201345.","journal-title":"Neurotherapeutics"},{"key":"539_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.coph.2017.10.005","volume":"37","author":"M Solas","year":"2017","unstructured":"Solas M, et al. Inflammation and gut-brain axis link obesity to cognitive dysfunction: plausible pharmacological interventions. Curr Opin Pharmacol. 2017;37:87\u201392.","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"539_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/microorganisms7010014","volume":"7","author":"E Rinninella","year":"2019","unstructured":"Rinninella E, et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 2019;7(1):14.","journal-title":"Microorganisms"},{"issue":"2","key":"539_CR16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/cells9020376","volume":"9","author":"T Hegelmaier","year":"2020","unstructured":"\u2022\u2022 Hegelmaier T, et al. Interventional influence of the intestinal microbiome through dietary intervention and bowel cleansing might improve motor symptoms in Parkinson\u2019s disease. Cells. 2020;9(2):376.\u00a0In PD patients, dietary modification and colon cleansing are acceptable approaches for modifying the gut microbiota and maybe enhancing clinical outcomes.","journal-title":"Cells"},{"key":"539_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11910-017-0802-6","volume":"17","author":"EM Quigley","year":"2017","unstructured":"Quigley EM. Microbiota-brain-gut axis and neurodegenerative diseases. Curr Neurol Neurosci Rep. 2017;17:1\u20139.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"11","key":"539_CR18","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1002\/alz.13007","volume":"19","author":"AH Dilmore","year":"2023","unstructured":"Dilmore AH, et al. Effects of a ketogenic and low-fat diet on the human metabolome, microbiome, and foodome in adults at risk for Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia. 2023;19(11):4805\u201316.","journal-title":"Alzheimer\u2019s & Dementia."},{"key":"539_CR19","doi-asserted-by":"publisher","first-page":"794640","DOI":"10.3389\/fneur.2021.794640","volume":"12","author":"C Rusch","year":"2021","unstructured":"Rusch C, et al. Mediterranean diet adherence in people with Parkinson\u2019s disease reduces constipation symptoms and changes fecal microbiota after a 5-week single-arm pilot study. Front Neurol. 2021;12:794640.","journal-title":"Front Neurol"},{"issue":"1","key":"539_CR20","first-page":"1","volume":"8","author":"D Ma","year":"2018","unstructured":"Ma D, et al. Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice. Sci Rep. 2018;8(1):1\u201310.","journal-title":"Sci Rep"},{"issue":"2","key":"539_CR21","first-page":"188","volume":"67","author":"S Park","year":"2020","unstructured":"Park S, et al. Ketone production by ketogenic diet and by intermittent fasting has different effects on the gut microbiota and disease progression in an Alzheimer\u2019s disease rat model. JCBN. 2020;67(2):188\u201398.","journal-title":"JCBN"},{"issue":"23","key":"539_CR22","doi-asserted-by":"publisher","first-page":"8877","DOI":"10.1021\/acs.jafc.2c07606","volume":"71","author":"C Chu","year":"2023","unstructured":"Chu C, et al. A low-protein, high-carbohydrate diet exerts a neuroprotective effect on mice with 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson\u2019s disease by regulating the microbiota-metabolite\u2013brain axis and fibroblast growth factor 21. J Agric Food Chem. 2023;71(23):8877\u201393.","journal-title":"J Agric Food Chem."},{"key":"539_CR23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neuroscience.2015.05.016","volume":"300","author":"K Magnusson","year":"2015","unstructured":"Magnusson K, et al. Relationships between diet-related changes in the gut microbiome and cognitive flexibility. Neuroscience. 2015;300:128\u201340.","journal-title":"Neuroscience"},{"key":"539_CR24","doi-asserted-by":"publisher","first-page":"110576","DOI":"10.1016\/j.nut.2019.110576","volume":"69","author":"N Saiyasit","year":"2020","unstructured":"\u2022 Saiyasit N, et al. Gut dysbiosis develops before metabolic disturbance and cognitive decline in high-fat diet\u2013induced obese condition. Nutrition. 2020;69:110576. The research shows that a high-fat diet initially leads to gut dysbiosis, which then progresses to brain pathology, resulting in cognitive decline.","journal-title":"Nutrition"},{"issue":"1","key":"539_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-019-0713-7","volume":"7","author":"J-M Li","year":"2019","unstructured":"Li J-M, et al. Dietary fructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: a benefit of short-chain fatty acids. Microbiome. 2019;7(1):1\u201314.","journal-title":"Microbiome"},{"key":"539_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2016.03.018","volume":"306","author":"JE Beilharz","year":"2016","unstructured":"Beilharz JE, Maniam J, Morris M. Short-term exposure to a diet high in fat and sugar, or liquid sugar, selectively impairs hippocampal-dependent memory, with differential impacts on inflammation. Behav Brain Res. 2016;306:1\u20137.","journal-title":"Behav Brain Res"},{"key":"539_CR27","doi-asserted-by":"publisher","first-page":"114068","DOI":"10.1016\/j.physbeh.2022.114068","volume":"260","author":"J Neto","year":"2023","unstructured":"Neto J, et al. Impact of cafeteria diet and n3 supplementation on the intestinal microbiota, fatty acids levels, neuroinflammatory markers and social memory in male rats. Physiol Behav. 2023;260:114068.","journal-title":"Physiol Behav"},{"issue":"1","key":"539_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-021-01172-0","volume":"9","author":"H Shi","year":"2021","unstructured":"Shi H, et al. A fiber-deprived diet causes cognitive impairment and hippocampal microglia-mediated synaptic loss through the gut microbiota and metabolites. Microbiome. 2021;9(1):1\u201320.","journal-title":"Microbiome"},{"issue":"5","key":"539_CR29","doi-asserted-by":"publisher","first-page":"e0217553","DOI":"10.1371\/journal.pone.0217553","volume":"14","author":"NG Deshpande","year":"2019","unstructured":"Deshpande NG, et al. High fat diet alters gut microbiota but not spatial working memory in early middle-aged Sprague Dawley rats. PLoS ONE. 2019;14(5):e0217553.","journal-title":"PLoS ONE"},{"issue":"1","key":"539_CR30","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1038\/s41598-018-23261-1","volume":"8","author":"E Sanguinetti","year":"2018","unstructured":"Sanguinetti E, et al. Microbiome-metabolome signatures in mice genetically prone to develop dementia, fed a normal or fatty diet. Sci Rep. 2018;8(1):4907.","journal-title":"Sci Rep"},{"key":"539_CR31","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jnutbio.2018.08.016","volume":"65","author":"P Zhang","year":"2019","unstructured":"Zhang P, et al. Alterations to the microbiota\u2013colon\u2013brain axis in high-fat-diet-induced obese mice compared to diet-resistant mice. J Nutr Biochem. 2019;65:54\u201365.","journal-title":"J Nutr Biochem"},{"key":"539_CR32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharmacol Sci. 1991;12:383\u20138.","journal-title":"Trends Pharmacol Sci"},{"key":"539_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.exger.2017.12.019","volume":"107","author":"A Le Page","year":"2018","unstructured":"Le Page A, et al. Role of the peripheral innate immune system in the development of Alzheimer\u2019s disease. Exp Gerontol. 2018;107:59\u201366.","journal-title":"Exp Gerontol"},{"key":"539_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2147\/JIR.S86958","volume":"9","author":"MR Bronzuoli","year":"2016","unstructured":"Bronzuoli MR, et al. Targeting neuroinflammation in Alzheimer\u2019s disease. J Inflamm Res. 2016;9:199.","journal-title":"J Inflamm Res"},{"key":"539_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.conb.2019.10.009","volume":"62","author":"H Hajjo","year":"2020","unstructured":"Hajjo H, Geva-Zatorsky N. Gut microbiota\u2013host interactions now also brain-immune axis. Curr Opin Neurobiol. 2020;62:53\u20139.","journal-title":"Curr Opin Neurobiol"},{"issue":"2","key":"539_CR36","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3233\/JAD-170908","volume":"62","author":"L Szablewski","year":"2018","unstructured":"Szablewski L. Human gut microbiota in health and Alzheimer\u2019s disease. J Alzheimers Dis. 2018;62(2):549\u201360.","journal-title":"J Alzheimers Dis"},{"issue":"13","key":"539_CR37","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.2174\/1567205015666180904155908","volume":"15","author":"VM Junges","year":"2018","unstructured":"Junges VM, et al. Crosstalk between gut microbiota and central nervous system: a focus on Alzheimer\u2019s disease. Curr Alzheimer Res. 2018;15(13):1179\u201390.","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"539_CR38","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1038\/s41598-017-02587-2","volume":"7","author":"L Bonfili","year":"2017","unstructured":"Bonfili L, et al. Microbiota modulation counteracts Alzheimer\u2019s disease progression influencing neuronal proteolysis and gut hormones plasma levels. Sci Rep. 2017;7(1):2426.","journal-title":"Sci Rep"},{"key":"539_CR39","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1016\/j.neurobiolaging.2014.03.038","volume":"35","author":"MC Morris","year":"2014","unstructured":"Morris MC, Tangney CC. Dietary fat composition and dementia risk. Neurobiol Aging. 2014;35:S59\u201364.","journal-title":"Neurobiol Aging"},{"issue":"7","key":"539_CR40","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.2174\/1570159X15666171017102547","volume":"16","author":"R Chianese","year":"2018","unstructured":"Chianese R, et al. Impact of dietary fats on brain functions. Curr Neuropharmacol. 2018;16(7):1059\u201385.","journal-title":"Curr Neuropharmacol"},{"issue":"4","key":"539_CR41","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/epi.14022","volume":"59","author":"N Gaspard","year":"2018","unstructured":"Gaspard N, et al. New-onset refractory status epilepticus (NORSE) and febrile infection\u2013related epilepsy syndrome (FIRES): state of the art and perspectives. Epilepsia. 2018;59(4):745\u201352.","journal-title":"Epilepsia"},{"key":"539_CR42","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3389\/fnins.2016.00611","volume":"10","author":"TW Tefera","year":"2017","unstructured":"Tefera TW, Borges K. Metabolic dysfunctions in amyotrophic lateral sclerosis pathogenesis and potential metabolic treatments. Front Neurosci. 2017;10:611.","journal-title":"Front Neurosci"},{"issue":"12","key":"539_CR43","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1194\/jlr.R046706","volume":"55","author":"ML Prins","year":"2014","unstructured":"Prins ML, Matsumoto JH. The collective therapeutic potential of cerebral ketone metabolism in traumatic brain injury. J Lipid Res. 2014;55(12):2450\u20137.","journal-title":"J Lipid Res"},{"issue":"2","key":"539_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1254\/jjp.87.143","volume":"87","author":"M Suzuki","year":"2001","unstructured":"Suzuki M, et al. Effect of \u03b2-hydroxybutyrate, a cerebral function improving agent, on cerebral hypoxia, anoxia and ischemia in mice and rats. Jpn J Pharmacol. 2001;87(2):143\u201350.","journal-title":"Jpn J Pharmacol"},{"issue":"10","key":"539_CR45","doi-asserted-by":"publisher","first-page":"5440","DOI":"10.1073\/pnas.97.10.5440","volume":"97","author":"Y Kashiwaya","year":"2000","unstructured":"Kashiwaya Y, et al. d-\u03b2-Hydroxybutyrate protects neurons in models of Alzheimer\u2019s and Parkinson\u2019s disease. Proc Natl Acad Sci. 2000;97(10):5440\u20134.","journal-title":"Proc Natl Acad Sci"},{"key":"539_CR46","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s13311-018-0666-8","volume":"15","author":"TJ McDonald","year":"2018","unstructured":"McDonald TJ, Cervenka MC. Ketogenic diets for adult neurological disorders. Neurotherapeutics. 2018;15:1018\u201331.","journal-title":"Neurotherapeutics"},{"issue":"4","key":"539_CR47","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000445751","volume":"46","author":"L Hirsch","year":"2016","unstructured":"Hirsch L, et al. The incidence of Parkinson\u2019s disease: a systematic review and meta-analysis. Neuroepidemiology. 2016;46(4):292\u2013300.","journal-title":"Neuroepidemiology"},{"issue":"1","key":"539_CR48","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41467-021-21027-4","volume":"12","author":"WK Man","year":"2021","unstructured":"Man WK, et al. The docking of synaptic vesicles on the presynaptic membrane induced by \u03b1-synuclein is modulated by lipid composition. Nat Commun. 2021;12(1):927.","journal-title":"Nat Commun"},{"issue":"1","key":"539_CR49","first-page":"1","volume":"8","author":"Q-J Yu","year":"2018","unstructured":"Yu Q-J, et al. Parkinson disease with constipation: clinical features and relevant factors. Sci Rep. 2018;8(1):1\u20139.","journal-title":"Sci Rep"},{"issue":"28","key":"539_CR50","doi-asserted-by":"publisher","first-page":"11337","DOI":"10.1097\/MD.0000000000011337","volume":"97","author":"F Yan","year":"2018","unstructured":"Yan F, et al. Gastrointestinal nervous system \u03b1-synuclein as a potential biomarker of Parkinson disease. Medicine. 2018;97(28):11337.","journal-title":"Medicine."},{"key":"539_CR51","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3389\/fnins.2019.00992","volume":"13","author":"A Mulak","year":"2019","unstructured":"Mulak A, et al. Fecal calprotectin as a marker of the gut immune system activation is elevated in Parkinson\u2019s disease. Front Neurosci. 2019;13:992.","journal-title":"Front Neurosci"},{"issue":"10","key":"539_CR52","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26307","volume":"30","author":"A Keshavarzian","year":"2015","unstructured":"Keshavarzian A, et al. Colonic bacterial composition in Parkinson\u2019s disease. Mov Disord. 2015;30(10):1351\u201360.","journal-title":"Mov Disord"},{"key":"539_CR53","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s10517-017-3700-7","volume":"162","author":"V Petrov","year":"2017","unstructured":"Petrov V, et al. Analysis of gut microbiota in patients with Parkinson\u2019s disease. Bull Exp Biol Med. 2017;162:734\u20137.","journal-title":"Bull Exp Biol Med"},{"issue":"3","key":"539_CR54","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans F, et al. Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov Disord. 2015;30(3):350\u20138.","journal-title":"Mov Disord"},{"issue":"1","key":"539_CR55","first-page":"27","volume":"7","author":"S Romano","year":"2021","unstructured":"Romano S, et al. Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation. npj PD. 2021;7(1):27.","journal-title":"npj PD"},{"key":"539_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-019-0175-7","volume":"8","author":"C Haikal","year":"2019","unstructured":"Haikal C, Chen Q-Q, Li J-Y. Microbiome changes: an indicator of Parkinson\u2019s disease? Transl Neurodegener. 2019;8:1\u20139.","journal-title":"Transl Neurodegener"},{"key":"539_CR57","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fnagi.2017.00206","volume":"9","author":"L Wang","year":"2017","unstructured":"Wang L, et al. Protein-restricted diets for ameliorating motor fluctuations in Parkinson\u2019s disease. Front Aging Neurosci. 2017;9:206.","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"539_CR58","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1080\/1028415X.2020.1859729","volume":"25","author":"E Cuevas","year":"2022","unstructured":"Cuevas E, et al. Tauroursodeoxycholic acid (TUDCA) is neuroprotective in a chronic mouse model of Parkinson\u2019s disease. Nutr Neurosci. 2022;25(7):1374\u201391.","journal-title":"Nutr Neurosci"},{"key":"539_CR59","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neuro.2021.01.002","volume":"83","author":"K Wang","year":"2021","unstructured":"Wang K, et al. Taurine improves neuron injuries and cognitive impairment in a mouse Parkinson\u2019s disease model through inhibition of microglial activation. Neurotoxicology. 2021;83:129\u201336.","journal-title":"Neurotoxicology"},{"issue":"1","key":"539_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-021-00273-y","volume":"10","author":"S Kim","year":"2021","unstructured":"Kim S, et al. Gram-negative bacteria and their lipopolysaccharides in Alzheimer\u2019s disease: pathologic roles and therapeutic implications. Transl Neurodegener. 2021;10(1):1\u201323.","journal-title":"Transl Neurodegener"},{"issue":"5","key":"539_CR61","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/glia.20467","volume":"55","author":"L Qin","year":"2007","unstructured":"Qin L, et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007;55(5):453\u201362.","journal-title":"Glia"},{"key":"539_CR62","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fnagi.2017.00007","volume":"9","author":"MN Vieira","year":"2017","unstructured":"Vieira MN, et al. Protein tyrosine phosphatase 1B (PTP1B): a potential target for Alzheimer\u2019s therapy? Frontiers Aging Neurosci. 2017;9:7.","journal-title":"Frontiers Aging Neurosci"}],"container-title":["Current Nutrition Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13668-024-00539-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13668-024-00539-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13668-024-00539-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T04:05:14Z","timestamp":1716955514000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13668-024-00539-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":62,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["539"],"URL":"https:\/\/doi.org\/10.1007\/s13668-024-00539-7","relation":{},"ISSN":["2161-3311"],"issn-type":[{"value":"2161-3311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,23]]},"assertion":[{"value":"2 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}